The Ethics of Placebo-Controlled Trials -- A Middle Ground

doi:10.1056/NEJM200109203451211

Volume 345:915-919		September 20, 2001		Number 12

The Ethics of Placebo-Controlled Trials — A Middle Ground

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

Full Text

PDF

Purchase this article

Editorial
by Huston, P.

Add to Personal Archive

Add to Citation Manager

Notify a Friend

E-mail When Cited

PubMed Citation

The first placebo-controlled trial was probably conducted in1931, when sanocrysin was compared with distilled water forthe treatment of tuberculosis.¹ Ever since then, placebo-controlledtrials have been controversial, especially when patients randomlyassigned to receive placebo have forgone effective treatments.²^,³^,⁴^,⁵Recently, the debate has become polarized. One view, dubbed"placebo orthodoxy" by its opponents, is that methodologic considerationsmake placebo-controlled trials necessary.⁶^,⁷^,⁸^,⁹^,¹⁰^,¹¹ The otherview, which might be called "active-control orthodoxy," is thatplacebo orthodoxy sacrifices ethics and the rights and welfareof patients to presumed scientific rigor.¹⁰^,¹¹^,¹²^,¹³^,¹⁴ Thelatest revision of the Declaration of Helsinki, although controversial,¹⁵^,¹⁶embraces . . . [Full Text of this Article]

Placebo Orthodoxy

Active-Control Orthodoxy

A Middle Ground

A Case Example

Conclusions

References

This article has been cited by other articles:

Dunlop, B W, Banja, J (2009). A renewed, ethical defense of placebo-controlled trials of new treatments for major depression and anxiety disorders. J. Med. Ethics 35: 384-389 [Abstract] [Full Text]
Zhou, J., Qu, F., Sang, X., Wang, X., Nan, R. (2009). Acupuncture and Auricular Acupressure in Relieving Menopausal Hot Flashes of Bilaterally Ovariectomized Chinese Women: A Randomized Controlled Trial. Evid Based Complement Alternat Med 0: nep001v1-nep001 [Abstract] [Full Text]
Fried, L. F., Duckworth, W., Zhang, J. H., O'Connor, T., Brophy, M., Emanuele, N., Huang, G. D., McCullough, P. A., Palevsky, P. M., Seliger, S., Warren, S. R., Peduzzi, P., for VA NEPHRON-D Investigators, (2009). Design of Combination Angiotensin Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor for Treatment of Diabetic Nephropathy (VA NEPHRON-D). CJASN 4: 361-368 [Abstract] [Full Text]
Kaufman, D. (2008). Fluconazole Prophylaxis Decreases the Combined Outcome of Invasive Candida Infections or Mortality in Preterm Infants. Pediatrics 122: 1158-1159 [Full Text]
Brown, J., Sobsey, M. D., Loomis, D. (2008). Local Drinking Water Filters Reduce Diarrheal Disease in Cambodia: A Randomized, Controlled Trial of the Ceramic Water Purifier. Am J Trop Med Hyg 79: 394-400 [Abstract] [Full Text]
Daugherty, C. K., Ratain, M. J., Emanuel, E. J., Farrell, A. T., Schilsky, R. L. (2008). Ethical, Scientific, and Regulatory Perspectives Regarding the Use of Placebos in Cancer Clinical Trials. JCO 26: 1371-1378 [Abstract] [Full Text]
van Saene, H., van Saene, J., Silvestri, L., de la Cal, M., Sarginson, R., Zandstra, D. (2007). Iseganan Failure Due to the Wrong Pharmaceutical Technology. Chest 132: 1412-1412 [Full Text]
The American Society of Clinical Oncology, (2007). Interactions With the Investment Industry: Practical and Ethical Implications. JCO 25: 338-340 [Full Text]
Miller, F G, Kaptchuk, T J (2007). Acupuncture trials and informed consent. J. Med. Ethics 33: 43-44 [Abstract] [Full Text]
Appel, L. J. (2006). A Primer on the Design, Conduct, and Interpretation of Clinical Trials. CJASN 1: 1360-1367 [Abstract] [Full Text]
Miller, P. B., Weijer, C. (2006). Fiduciary Obligation in Clinical Research. J Law Med Ethics 34: 424-440
Bola, J. R (2006). Medication-Free Research in Early Episode Schizophrenia: Evidence of Long-Term Harm?. Schizophr Bull 32: 288-296 [Abstract] [Full Text]
Miller, F. G, Wendler, D. (2006). The Relevance of Empirical Research in Bioethics. Schizophr Bull 32: 37-41 [Abstract] [Full Text]
Dunn, L. B, Candilis, P. J, Roberts, L. W. (2006). Emerging Empirical Evidence on the Ethics of Schizophrenia Research. Schizophr Bull 32: 47-68 [Abstract] [Full Text]
Shore, D. (2006). Ethical Issues in Schizophrenia Research: A Commentary on Some Current Concerns. Schizophr Bull 32: 26-29 [Abstract] [Full Text]
Nagasako, E. M., Kalauokalani, D. A. (2005). Ethical aspects of placebo groups in pain trials: Lessons from psychiatry. Neurology 65: S59-S65 [Abstract] [Full Text]
Brody, B. A., McCullough, L. B., Sharp, R. R. (2005). Consensus and Controversy in Clinical Research Ethics. JAMA 294: 1411-1414 [Full Text]
Woods, S. W., Gueorguieva, R. V., Baker, C. B., Makuch, R. W. (2005). Control Group Bias in Randomized Atypical Antipsychotic Medication Trials for Schizophrenia. Arch Gen Psychiatry 62: 961-970 [Abstract] [Full Text]
Krieger, J. W., Takaro, T. K., Song, L., Weaver, M. (2005). The Seattle-King County Healthy Homes Project: A Randomized, Controlled Trial of a Community Health Worker Intervention to Decrease Exposure to Indoor Asthma Triggers. AJPH 95: 652-659 [Abstract] [Full Text]
Lichtenberg, P, Heresco-Levy, U, Nitzan, U (2004). The ethics of the placebo in clinical practice. J. Med. Ethics 30: 551-554 [Abstract] [Full Text]
Bakheit, A M O, Fedorova, N V, Skoromets, A A, Timerbaeva, S L, Bhakta, B B, Coxon, L (2004). The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles. J. Neurol. Neurosurg. Psychiatry 75: 1558-1561 [Abstract] [Full Text]
Miller, F. G. (2004). Research Ethics and Misguided Moral Intuition. J Law Med Ethics 32: 111-116
Miller, F. G., Silverman, H. J. (2004). The Ethical Relevance of the Standard of Care in the Design of Clinical Trials. Am. J. Respir. Crit. Care Med. 169: 562-564 [Full Text]
Miller, F. G., Emanuel, E. J., Rosenstein, D. L., Straus, S. E. (2004). Ethical Issues Concerning Research in Complementary and Alternative Medicine. JAMA 291: 599-604 [Abstract] [Full Text]
Eichenfield, L. F., Lucky, A. W., Boguniewicz, M., Langley, R. G. B., Cherill, R., Marshall, K. (2003). 1% Pimecrolimus Cream for Atopic Dermatitis. Arch Dermatol 139: 1369-1370 [Full Text]
Kim, S. Y.H., Holloway, R. G. (2003). Burdens and Benefits of Placebos in Antidepressant Clinical Trials: A Decision and Cost-Effectiveness Analysis. Am. J. Psychiatry 160: 1272-1276 [Abstract] [Full Text]
Fleischhacker, W. W., Czobor, P., Hummer, M., Kemmler, G., Kohnen, R., Volavka, J. (2003). Placebo or Active Control Trials of Antipsychotic Drugs?. Arch Gen Psychiatry 60: 458-464 [Abstract] [Full Text]
Chen, D. T., Miller, F. G., Rosenstein, D. L. (2003). Clinical Research and the Physician-Patient Relationship. ANN INTERN MED 138: 669-672 [Abstract] [Full Text]
Grunberg, S. M., Cefalu, W. T. (2003). The Integral Role of Clinical Research in Clinical Care. NEJM 348: 1386-1388 [Full Text]
The PREVENT Investigator Group, (2002). Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clinically important venous thromboembolism in medical patients: the Prospective Evaluation of Dalteparin efficacy for Prevention of Venous Thromboembolism in Immobilized Patients Trial (the PREVENT study). Vasc Med 7: 269-273 [Abstract]
Caballero, B. (2002). Ethical issues for collaborative research in developing countries. Am. J. Clin. Nutr. 76: 717-720 [Full Text]
Orentlicher, D. (2002). Universality and its Limits: When Research Ethics Can Reflect Local Circumstances. J Law Med Ethics 30: 403-410
Hirsch, I. B., Coviello, A., Mazuski, J. E., Bailey, J. A., Shapiro, M. J., McCowen, K. C., Maykel, J. A., Bistrian, B. R., Nusbaum, N. J., van den Berghe, G., Bouillon, R., Lauwers, P. (2002). Intensive Insulin Therapy in Critically Ill Patients. NEJM 346: 1586-1588 [Full Text]
Weijer, C. (2002). I Need a Placebo like I Need a Hole in the Head. J Law Med Ethics 30: 69-72
(2002). The better-than-nothing idea: debating the use of placebo controls. CMAJ 166: 573-573 [Full Text]
(2002). Debat sur l'utilisation des placebos controles. CMAJ 166: 575-575 [Full Text]
Weijer, C., Glass, K. C., Emanuel, E. J., Miller, F. G. (2002). The Ethics of Placebo-Controlled Trials. NEJM 346: 382-383 [Full Text]
Huston, P., Peterson, R. (2001). Withholding Proven Treatment in Clinical Research. NEJM 345: 912-914 [Full Text]

Comments and questions? Please contact us.